Abstract:Advanced stage high grade serous ovarian cancer (HGSC) metastasizes preferentially to the omentum, which is a well-vascularized fold of peritoneal tissue covered by mesothelial cells and a major site of intra-abdominal fat accumulation. We previously reported that HGSC cells interact with mesothelial cells in the visceral adipose tissue by downregulating omentin, a novel adipokine, to promote the invasive potential and proliferation of cancer cells in the omental tumor microenvironment (TME). In addition, omentin induces a local rapid metabolic coupling between ovarian cancer cells and neighboring adipocytes by upregulating GLUT4 in adipocytes, which subsequently deprives glucose in the omental TME and suppresses HGSC cell progression. Besides the crosstalk between cancer cells and neighboring adipocytes and mesothelial cells play a role in modulating the malignant phenotypes of HGSC cells, crosstalk between cancer cells and other stromal cell types particularly the immune cells such as macrophages and T cells may also play a role. Our preliminary data showed that mice treated with recombinant omentin had markedly increased in activated CD8+ T cell density in the omental TME compared to the untreated control, suggesting that mesothelial cell-derived omentin may enhance immune surveillance in the omental TME and subsequently suppress HGSC progression. Therefore, in this study, we aim at further investigating the roles of omentin in modulating the crosstalk between adipocytes and various immune cells to enhance the immune surveillance in the immunosuppressive omental TME. Since adipocyte is one of the major cell types in the omental TME, we focus on identifying secretory proteins that can be upregulated by omentin in mature adipocytes and have been shown to play a role in reprogramming the immunosuppressive TME. We found that TSG-6 was the top gene upregulated by omentin in adipocytes. Furthermore, we demonstrated that TSG-6 neutralizing antibody attenuated the omentin-mediated suppressive effect on ovarian cancer invasive potential and prevented the binding of regulatory T cells to endothelial cells mediated by CXCL12. We also found that recombinant TSG-6 protein attenuated the CXCL12-induced Ca2+ mobilization in ovarian cancer cells. These findings suggest that TSG-6 mediates the effect of omentin in alleviating immune escape in ovarian cancer by blocking pro-inflammatory CXCL12-mediated signaling events, which might attenuate regulatory T cell trafficking to the tumor tissue, subsequently enhance CD8+ T cell activity and eventually suppress the malignant phenotypes. In conclusion, based on the above findings, further studies to delineate the roles of omentin/TSG-6 axis in modulating immune surveillance in HGSC and to develop omentin as a chemopreventive and therapeutic agent in the treatment of HGSC to improve patients' survival rates are warranted. Citation Format: Chi Lam Au Yeung, Kay-Pong Yip, Karen H Lu, Deepak Nagrath, Samuel C Mok. Omentin: A novel immune modulator in the pro-inflammatory omental microenvironment of high-grade serous ovarian cancer [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2) nr B067.

Effect of Omentin-1 on Cancer Stem Cell Surface Markers and Tumour-Suppressive Mirna Expression in a High-Glucose Environment Associated with Colorectal Cancer.

The Effect of Omentin-1 on the Proliferation and Apoptosis of Colon Cancer Stem Cells and the Potential Mechanism.

Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer Cells

ZEB1 Promotes Oxaliplatin Resistance Through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells

Tumour Microenvironment Changes after Osimertinib Treatment Resistance in Non-Small Cell Lung Cancer.

Abstract A001: Colorectal Cancer Cell-Derived Exosomes Containing Mir-183-5p Regulate Angiogenesis Via FOXO1

The Association Between Chinese Patients' Elevated Omentin-1 Levels, Their Clinicopathological Features, and the Risk of Colorectal Cancer.

Abstract B067: Omentin: A novel immune modulator in the pro-inflammatory omental microenvironment of high-grade serous ovarian cancer

Autocrine Action of Adipokine Omentin-1 in the SW480 Colon Cancer Cell Line.

Orosomucoid 1 Promotes Epirubicin Resistance in Breast Cancer by Upregulating the Expression of Matrix Metalloproteinases 2 and 9

The Effect of Metformin on the Proliferation, Apoptosis and CD133 mRNA Expression of Colon Cancer Stem Cells by Upregulation of miR 342-3p

Omentin-1, a New Adipokine, Promotes Apoptosis Through Regulating Sirt1-dependent P53 Deacetylation in Hepatocellular Carcinoma Cells.

Expression of Omentin in Intestine of Mice Before and after Oral Glucose Uptake and Effects of Omentin on Insulin Sensitivity in C2C12 Myotubes

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway

Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer

Effect of Tumor-Associated Macrophages on Gastric Cancer Stem Cell in Omental Milky Spots and Lymph Node Micrometastasis.

Effect of antibiotic monensin on cell proliferation and IGF1R signaling pathway in human colorectal cancer cells

Inhibition of Microrna-218 Promotes Oral Squamous Cell Carcinoma Growth by Targeting GLUT1 to Affect Glucose Metabolism

STON2 Negatively Modulates Stem-Like Properties in Ovarian Cancer Cells Via DNMT1/MUC1 Pathway.

Effects and Mechanism of RhoC Downregulation in Suppressing Ovarian Cancer Stem Cell Proliferation, Drug Resistance, Invasion and Metastasis

Elevated Oct1 Participates in Colon Tumorigenesis and Independently Predicts Poor Prognoses of Colorectal Cancer Patients